IRIS
GENTILE, Ivan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.934
EU - Europa 2.132
AS - Asia 1.384
AF - Africa 96
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 7.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.821
IT - Italia 986
SG - Singapore 871
CN - Cina 446
NL - Olanda 383
DE - Germania 180
IE - Irlanda 169
FI - Finlandia 163
CA - Canada 111
CI - Costa d'Avorio 85
UA - Ucraina 61
GB - Regno Unito 50
FR - Francia 43
IN - India 32
CH - Svizzera 25
SE - Svezia 24
RU - Federazione Russa 17
VN - Vietnam 11
EG - Egitto 8
TR - Turchia 7
BE - Belgio 6
BR - Brasile 6
AT - Austria 5
CZ - Repubblica Ceca 5
EU - Europa 4
HK - Hong Kong 3
IR - Iran 3
LT - Lituania 3
PK - Pakistan 3
ES - Italia 2
JP - Giappone 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 7.558
Salva come PNG Salva come JPEG
Città #
Singapore 725
Chandler 608
Santa Clara 386
Amsterdam 364
Naples 305
Ashburn 283
Millbury 240
Des Moines 145
Princeton 136
Nanjing 126
Napoli 123
Boston 108
Ottawa 92
Lawrence 82
Beijing 76
Boardman 62
Wilmington 56
Nanchang 41
Rome 39
Jacksonville 36
Krefeld 32
Helsinki 31
Shenyang 28
Hebei 26
Dublin 23
Milan 23
Washington 23
Houston 22
Seattle 22
Jiaxing 21
Tianjin 20
Basel 17
Los Angeles 17
Kronberg 15
Marseille 14
Pune 14
Ann Arbor 13
Caserta 13
Changsha 13
Norwalk 13
Frankfurt am Main 12
Pozzuoli 12
Lappeenranta 11
Munich 11
Dallas 10
Falkenstein 10
Fisciano 10
Formia 9
Indiana 9
Bologna 8
Dong Ket 8
Pomigliano D'arco 8
Toronto 8
Boise 7
Council Bluffs 6
London 6
Redwood City 6
Woodbridge 6
Brussels 5
Casalnuovo Di Napoli 5
Falls Church 5
Guangzhou 5
Hangzhou 5
Latina 5
Mugnano di Napoli 5
Shanghai 5
Agropoli 4
Cairo 4
Castellammare di Stabia 4
Chicago 4
Fremont 4
Jinan 4
Moscow 4
Padova 4
Qualiano 4
Richmond 4
Salerno 4
Sorrento 4
The Dalles 4
Torre del Greco 4
Acerra 3
Aversa 3
Bari 3
Brescia 3
Brno 3
Campagna 3
Cercola 3
Cologno Monzese 3
Dung 3
Geneva 3
Hanover 3
Hong Kong 3
Istanbul 3
Lanzhou 3
Mariglianella 3
Melito di Napoli 3
Montalbano Jonico 3
Mumbai 3
New York 3
Nuremberg 3
Totale 4.746
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 133
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 77
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 69
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 66
Infezione da cytomegalovirus 61
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 60
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 58
HIV and hepatitis C virus: facts and controversies 57
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 56
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 56
[HBV and pregnancy]. 55
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 54
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 54
Asunaprevir for hepatitis C: A safety evaluation 54
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 54
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 54
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 53
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 52
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 51
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 51
Does compulsory vaccination limit personal freedom? Ethical issues 51
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 49
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. 49
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 48
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 46
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 46
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 46
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 45
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 45
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 44
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 44
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 44
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 43
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 43
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 43
Febbre di origine sconosciuta (FUO): nostra casistica 42
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 42
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 42
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 42
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 42
Current evidence on the management of hepatitis B in pregnancy 41
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 41
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 41
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 41
Beclabuvir for the treatment of hepatitis C 41
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 41
Il Virus varicella Zoster 41
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 41
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 40
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 40
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 40
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 40
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 40
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 39
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 39
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 39
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 39
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 39
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 39
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 39
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 39
The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism 39
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 39
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 38
Compromissione cognitiva subclinica in pazienti HCV-positivi 38
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 38
A pill a day keeps HCV away 37
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 37
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 37
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 37
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 37
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 37
Chest CT in COVID-19 patients: structured vs conventional reporting 37
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 37
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 36
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 36
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 36
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 35
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 35
Virological patterns of HCV patients with failure to interferon-free regimens 35
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 35
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 35
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 35
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 35
Noninvasive prediction of oesophageal varices: As simple as blood count? 34
Epstein-Barr virus 34
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 34
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 34
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 34
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 33
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 33
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 33
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 33
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 33
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 33
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis 33
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 33
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients 33
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 33
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 32
Totale 4.334
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 0 8 5 11 6 42 79 49
2020/2021341 27 12 22 17 57 40 44 13 42 27 21 19
2021/20221.207 15 8 17 11 8 38 20 45 162 75 270 538
2022/20232.034 227 113 52 98 206 204 44 276 306 365 85 58
2023/20241.543 68 217 278 91 90 173 40 149 32 27 227 151
2024/20251.584 360 369 54 171 239 391 0 0 0 0 0 0
Totale 8.066